Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-06

FDA Approved: MAXI NICOTINE — Original Application (Walgreens)

View source ↗

Summary

The FDA approved MAXI NICOTINE (nicotine polacrilex) under an original application (Walgreens) as a nicotine replacement therapy product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MAXI NICOTINE (NICOTINE POLACRILEX)

Snippet

ORIG AP for MAXI NICOTINE (NICOTINE POLACRILEX)